JPRN-UMIN000011180已完成2 期
Randomized phase II study of two induction treatments of melphalan, prednisolone, plus bortezomib, JCOG-MPB versus modified PETHEMA-MPB, in elderly patients or non-elderly patients refusing transplant with untreated symptomatic myeloma(JCOG1105, IMPROVE-MPB study) - Randomized phase II study of two induction treatments, JCOG-MPB versus modified PETHEMA-MPB, in elderly patients or non-elderly patients refusing transplant with untreated symptomatic myeloma(JCOG1105, IMPROVE-MPB study)
Japan Clinical Oncology Group (JCOG)0 个研究点目标入组 91 人开始时间: 2013年7月12日最近更新:
适应症
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 发起方
- 入组人数
- 91
研究概览
简要总结
See the datails via "URL releasing results" above. Also the details can be seen in the JCOG website: http://www.jcog.jp/en/trials/index.html
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 79years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1) Synchronous or metachronous malignancy 2) Active infection 3) Pregnant or nursing women 4) Psychiatric disease 5) Continuous systemic treatment with steroids for non-malignant disorders 6) Insulin-dependent or uncontrollable diabetes mellitus 7) Uncontrollable hypertension 8) HBs-Ag positive or HCV-Ab positive 9) HIV-Ab positive 10) Interstitial pneoumonia, pulmonary fibrosis, severe pulmonary emphysema, or severe pleural effusion on chest CT 11) Uncontrollable Glaucoma 12) Allergic history to borate or mannitol
研究者
相似试验
已完成
2 期
Randomized phase II study of the Induction Chemotherapy with Docetaxel alone vs CDDP+Docetaxel for c-stage IB-II Non-Small Cell Lung Cancer (JCOG 0204-MF)JPRN-C000000032Japan Clinical Oncology Group(JCOG)80
已完成
2 期
Randomized phase II trial of CODE or amrubicin and cisplatin chemotherapy following concurrent cisplatin, etoposide and accelerated hyperfractionation thoracic radiotherapy for limited disease small cell lung cancer (JCOG1011, LD-SCLC/CODE vs AP)JPRN-UMIN000005342Japan Clinical Oncology Group (JCOG)80
已完成
2 期
Randomized phase II study of gemcitabine and S-1 combination therapy versus S-1 in advanced biliary tract cancer. (JCOG 0805)biliary tract neoplasmJPRN-UMIN000001685Japan Clinical Oncology Group(JCOG)100
已完成
2 期
Randomized phase II study of best available 5-FU versus low-dose Paclitaxiel in gastric cancer with peritoneal metastasis refractory to 5-FU containing regimen(JCOG0407)gastric neoplasmJPRN-C000000138Japan Clinical Oncology Group(JCOG)100
已完成
2 期
Phase II trial of chemoradiotherapy concurrent with S-1 plus cisplatin in patients with unresectable locally advanced squamous cell carcinoma of the head and neck (JCOG0706)JPRN-UMIN000001272Japan Clinical Oncology Group (JCOG)45